Losses
-€675,080 in six years
Every financial year from 2021 to 2026 closed with a loss. 2025 was the heaviest.
ISOMED
Lifetime
20 annual accounts with figures on one time axis, 39 filings since 1987peak €868,775 (2020)
€302▲ €68,896
lowest -€469,398 (2009)
-€157,886▲ €38,758
peak €2.1m (2024)
€1.8m▼ 8.1%
€2.0m▲ 16.9%
peak 0 FTE (2017)
-not published
Board1 name since 2021
1 director
Owners2 names in the annual accounts
Documentsfilings and deeds
29-10-20262 days before the deadline
2026abbreviated format
Gross margin from -€68,595 to €302Loss of €157,886Debts from €1.7m to €2.0mCash from €121,551 to €38,561
Key points
from the 2026 annual accountsFilings
39 annual accounts since 1987
The 2020 accounts came 4 days late. The other nine of the last ten were filed on time.
At the same address
18 companies
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 8,613 companies had the same profile as ISOMED has now. Each dot stands for 22 companies, two years later.
94.1%
were still trading
5.2%
stopped another way
0.4%
went bankrupt
Another 0.2% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 8,613 companies, not a prediction for ISOMED. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director, since 13-12-2021
- 91.61%equity -€983,653 (2025) · 30-09-2025 annual accounts of
Recent changes
Capital increase of €2,002,567.34
8,190 new shares · Contribution: · General meeting of 27-03-2024 · Gazette deed
Resignation: (director)
Appointment: (director) · Legal-form conversion: from private limited company (pre-2019) to private limited company · General meeting of 13-12-2021 · Gazette deed
Registered office moved within Ghent
New registered office: Kouter 7-A bus 201, 9000 Gent · Previous registered office: Kouter 7-B bus 201-9000 Gent · General meeting of 24-03-2020 · Gazette deed
Registered office moved from Sint-Martens-Latem to Ghent
New registered office: Kouter 7-B bus 201-9000 Gent · Previous registered office: Eikeldreef 47, 9830 Sint-Martens-Latem · General meeting of 24-03-2020 · Gazette deed
Official details
Source: KBO- Status
- Active since 13-03-1986Normal situation
- Registered office
- 13 active companies are registered at this addressSource: KBO register, as of 13 November 2026.
- Activity
- “Het uitbaten van een medisch secretariaat,zoals voor eigen rekening als voor rekening van derden,evenals…” (deed in Dutch)From the articles, 3 activitiesNo NACE code in the KBO yet
- Establishment unit
- 2.037.141.5409000 Ghent, since 14-05-1986
- Financial year end
- 31 March
- Peppol
- Not found in the Peppol Directory
Annual accounts to 31-03-2026
- ≈ €2,200estimated
- €4.0m▲ 3.1%
- Filing
- Filed on 29-10-2026, 2 days before the end of the filing period
Insights on ISOMED
ISOMED files the abbreviated format. That format states no turnover. The gross margin fell from €529,853 in 2007 to €302 in 2026.
The balance sheet grew most in 2024 through fixed assets.
holds 91.61% of the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about ISOMED
- What is the company number of ISOMED?
- The company number of ISOMED is 0428.638.149. The VAT number is the same number with BE in front: BE 0428.638.149.
- Where is ISOMED based?
- The registered office is at Kouter 7-A, 9000 Ghent.Company details
- What is the legal form of ISOMED?
- ISOMED is a private limited company (BV).
- When was ISOMED founded?
- ISOMED was founded on 13-03-1986.
- Is ISOMED still active?
- Yes, ISOMED is an active enterprise in the KBO register.
- What is the turnover of ISOMED?
- The turnover in financial year 2026 is ≈ €2,200. This figure is estimated from the gross margin of €302 and 1,933 comparable companies of the same size. It probably lies between €860 and €5,600. It is a rough estimate.Financials
- Is ISOMED profitable?
- In financial year 2026, ISOMED made a loss of €157,886.
- Where can I find the annual accounts of ISOMED?
- ISOMED filed 39 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
- When are the next annual accounts of ISOMED due?
- ISOMED must file the annual accounts for financial year 2027 by 31-10-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.